TRAF3IP3 and COVID-19: Several genomic and methylation studies on COVID-19 have found that TRAF3IP3 can serve as a potential epigenetic biomarker for COVID-19 and is a key mutated region in severe patients, compared with non-severe COVID-19 patients [49,50].